CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 63 enrolled
Drug / intervention
Pioglitazone +1 moredrug
Likely dose
Pioglitazone 30mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01748994
NCT01748994N/ACompleted
CompareCT.gov

Cellular Dynamics of Subcutaneous Fat Distribution in Obese Women

Pennington Biomedical Research Center·interventional·Posted Dec 13, 2012·Updated Apr 30, 2021

In Brief

A clinical study evaluating Pioglitazone and Placebo for Obesity and Metabolic Syndrome. Completed, enrolled 63 participants across 2 sites.

Detailed Summary

The body shape of obese women varies between having the majority of fat either above the waist ("apple" shape) or below the waist ("pear" shape). The study will investigate what restricts: apple"-shaped women from being "pear"-shaped at the cellular level. Since "pear" shaped women tend to have better health, this study will open the door to future research in regulating body shape and thus improving health.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsObesity, Metabolic Syndrome
CountriesUnited States
CollaboratorsNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedDec 13, 2012
Enrollment StartFeb 1, 2011
Primary CompletionDec 1, 2016
TodayJul 2, 2026
Enrollment to primary: 5.8 yearsPosted 13.6 years ago

Interventions

Pioglitazonedrug

30mg per day for four months

Placebodrug